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Laser ablation inductively coupled plasma mass spectrometry (LA ICP-MS) was employed to 
image deposits of calcium phosphate based crystals in knee cartilage and synovial fluid from 
arthritic patients. A reaction / collision cell that contained  hydrogen minimised plasma 10 
interferences on calcium and also improved the image quality without significant sensitivity 
reduction. Areas of high calcium and phosphorus intensities consistent with crystal deposits were 
observed for both the cartilage and synovial fluid samples. These areas were also characterised by 
high magnesium and strontium intensities. Distribution patterns of other elements such as copper 
and sulfur did not correlate with the crystal deposits. Filtered and non-filtered solutions of calcium 15 
phosphate crystals grown in synthetic synovial fluid were also imaged as further evidence of 
crystals deposits. The crystal deposits were detected in the unfiltered solution, and absent from the 
filtered solutions. 
Intoduction 
The importance of calcium pyrophosphate dihydrate (CPPD) 20 
and basic calcium phosphates (BCP) in rheumatology was 
first discovered in the early 1960’s1. Since then, the 
concurrence of BCP (hydroxyapatite, octacalcium phosphate, 
tricalcium phosphate) and CPPD crystals and degenerative 
joint disease has been well established. Though there is ample 25 
data available to support the role of BCP crystals in cartilage 
degeneration, it is still unclear whether other calcium-
containing crystals play a direct driving role in disease 
conception and progression, or are merely markers of joint 
damage2-4.  30 
 The identification of specific crystal types in synovial fluid 
is currently the most popular method of diagnosing all 
common forms of crystal-associated arthritis3. In general, 
crystal arthritides cannot be distinguished from other causes 
of arthritis based on history or physical examination5. Despite 35 
the multitude of techniques that have been applied to BCP and 
CPPD crystal detection, clinical diagnosis almost exclusively 
relies on light microscopy (LM). However, LM lacks the 
resolution required to image small crystals (<1µm), is non-
specific (though CPPD crystals can generally be distinguished 40 
under polarised LM) and accuracy is operator dependent3, 5-7. 
Sensitivity can be improved by staining the sample with 
calcium specific dyes particularly for BCP crystals which are 
often too small to be seen by LM. However these are often 
subject to false positives. 45 
 Other techniques for the determination of BCP crystals 
include scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM).  These methods are expensive, 
complex and not widely available for routine analysis in a 
clinical setting. Techniques recently applied to crystal 50 
detection and identification include atomic force microscopy 
(AFM), Fourier-transform infrared spectroscopy (FTIR) and 
Raman spectroscopy. AFM and Raman show great potential 
for this application. Additionally, FTIR and Raman 
spectrometers may be made compact, making the technology 55 
capable of point-of-care operation3. A comprehensive review 
of the analytical tools available for the detection and 
identification of calcium phosphate crystals was recently 
published by Yavorskyy, et al3. The review made it evident 
that a simple, inexpensive technique which is capable of 60 
detecting and identifying calcium phosphate-based crystals 
accurately and with a high sensitivity would be invaluable in 
the diagnosis of crystal associated arthritides. 
 Laser ablation inductively coupled plasma mass 
spectrometry (LA ICP-MS) is increasingly applied to the 65 
study of metals in biological samples8, 9. LA ICP-MS offers 
direct multielemental analysis of solids and liquids with trace 
and ultra trace detection capabilities, and a linear dynamic 
range of seven or more orders of magnitude. Though its 
application to imaging of soft tissues is emerging, it is 70 
considered a mature technique for the analysis of geological 
and metallurgical samples10. In LA ICP-MS systems, a 
focussed laser beam is used to mobilise sample material as 
droplets or vapour from the sample surface9. The material is 
then transported to the plasma (usually by argon carrier gas) 75 
where the material is ionised and carried through to the mass 
spectrometer which selectively detects ions at a given mass-
to-charge ratio. 
 LA ICP-MS may be utilised to construct maps that provide 
elemental spatial information at trace and bulk levels of 80 
biological samples such as small tumours in rat brains11, β-
amyloid plaques in mouse models of Alzheimer’s disease12, 
and the distribution of platinum in mouse kidneys treated with 
cis-platin13. The environmental sciences have also utilised the 
potential of this technique to analyse the environmental 85 
changes or pollutant accumulation evident from the changing 
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metal concentrations in increment growth layers of many 
types of organisms such as scales, shells, otoliths and tree 
xylem14. 
 Recently, Chaudhri et al.,15 determined the elemental 
distribution of bladder and kidney stones by LA ICP-MS. LA  5 
ICP-MS has also been employed to study element time 
profiles in teeth16 and bones17, and to determine strontium 
ratios in calcium phosphates18. Quantitative analysis of heavy 
metals in bone employing reference standards and spiking 
hydroxapatite standards has also been reported 19, 20 17. 10 
However, LA-ICP-MS has not been used to image crystal 
deposits in biological samples. Element concentrations in 
synovial fluids from osteoarthritic patients have been 
determined by ICP-MS21.  
 This study demonstrates the potential of LA ICP-MS for 15 
crystal detection in biological samples. Cartilage sections 
were obtained from knee or hip arthroplasty and were imaged 
by LA ICP-MS for the presence of crystal-associated 
elements. Additionally, eight synovial fluid samples, six from 
patients diagnosed with osteoarthritis (OA) and two from 20 
patients diagnosed with rheumatoid arthritis (RA), were 
analysed by the same method. Results from each sample type 
are presented here. We propose that this method of analysis be 
termed “Elemental Bioimaging”. 
Experimental 25 
Instrumental and measurement procedure 
A quadropole 7500ce ICP-MS (Agilent Technologies) with 
octopole collision/reaction cell and cs lenses installed was 
coupled to a New Wave UP213 laser ablation unit for the 
generation of elemental images of biological samples from 30 
arthritic patients. 
 Laser ablation of biological samples was performed using a 
frequency quintupled Nd:YAG laser with ablated material 
transported to the ICP-MS via a stream of argon carrier gas. 
The ICP-MS was operated in reaction gas mode to reduce the 35 
interferences on calcium and strontium isotopes. The 
optimised experimental parameters for LA ICP-MS analysis 
were recorded in Table 1. Cartilage samples (generally less 
than 10×10mm) were imaged in approximately 20hrs, whilst 
synovial fluid took approximately 2.5hrs to image. 40 
Table XX Caption 
 
Agilent 7500ce ICP-MS New Wave UP213 Laser Ablation 
Rf Power 1370W Wavelength 213nm 
Cooling gas flow rate 15 l min-1 Repetition frequency 20Hz 
Carrier gas flow rate 1.25 l min-1 Laser energy density 0.2J cm-2 (at 30%) 
Hydrogen flow rate 2.5ml min-1 Cartilage Samples  
Sample Depth  5.0mm Spot size 55 µm 
QP Bias -16V Scan rate 30 µm s-1 
OctP Bias -20V Synovial Fluid  
Scan mode Peak hopping Spot size 100 µm 
Dwell time  0.1s, 0.2s for P Scan rate 40 µm s-1 
  Synthetic Synovial Fluid  
  Spot size 55 µm 




 Imaging was performed using the software package ENVI 
v4.2 (Research Systems Inc., Boulder, CO, USA). The 45 
samples were systematically scanned across the entire area of 
the sample. For cartilage samples, the distance between 
adjacent scan lines was 29µm, which ensured complete 
ablation of the tissue sample. For the synovial spots, the line 
scans were placed 50 µm apart. The data files generated by 50 
ChemStation (Agilent Technologies) were then collected and 
imported into ENVI. As no quantification data was collected, 
images only show relative signal intensities.  
Sample Preparation 
All experiments were performed in compliance with the 55 
relevant laws and institutional guidelines of the University of 
Technology Sydney and Stanford University. The study was 
approved by the ethics committees of the University of 
Technology Sydney and Stanford University. Human samples 
were collected at Stanford University after informed consent 60 
and under Institutional Review Board (IRB)-approved 
protocols. Cartilage sections were obtained after either knee 
or hip arthroplasty. Sections were cut to 14µm thick dried. 
Synovial fluid was aspirated from inflamed knee joints, 
centrifuged at 2000rpm and the supernatant collected and 65 
frozen, within 4 hours of collection, for storage. Synovial 
fluid was dropped (12µl) onto quartz cover slips and dried for 
analysis by LA ICP-MS. 
 Synthetic synovial fluid was prepared from human serum  
(Sigma, Germany) by mixing equal volumes (30%) of 70 
laboratory grade (Ajax, Sydney) 10mM calcium chloride, 
50mM tetrasodium pyrophosphate and 7mM magnesium 
sulphate according to a method reported by Cheng for crystal 
formation of CPPD in aqueous solutions22, 23. 
Tris(hydroxymethyl)methylamine (Ajax, Sydney) was added 75 
to maintain the pH around physiological levels. The calcium, 
magnesium and pyrophosphate salts were chosen based on the 
assumption that their counter ions would not form precipitates 
in the synthetic synovial solution. The synthetic synovial fluid 
was then left in the oven at 37°C for 2 weeks to encourage 80 
crystal formation. A disposable 0.22µm syringe filter was 
used to remove any large particles from solution. Both filtered 
and non-filtered solutions were dropped (5µl) onto a clean 
quartz slide and air dried before analysis by LA ICP-MS. 
 This journal is © The Royal Society of Chemistry [year]
Fig. 1 Elemental distribution maps of calcium (43
from a patient diagnosed with osteoarthritis 5 
Results and Discussion 
Imaging of Cartilage Samples 
Cartilage examination for crystals can provide important 
information regarding the progression of the disease. For 
example, the density of crystals has been shown to correlate 10 
with the degree of mechanical stress exerted on the involved 
joint2.  
 Initial experiments attempted to generate images with the 
reaction cell operating only as an ion g
image signal was poor in quality due to a high background. 15 
Investigations into methods of background attenuation for 
calcium lead to experimentation with the octopole collision / 
reaction cell with hydrogen and helium, as well as utilisin
the cool plasma technique24-27. Experiments were performed 
using an in-house prepared plastic standard which contained 20 
all the elements of interest. 
 Use of a cool plasma and helium collision gas decreased the 
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Ca), phosphorus (31P), magnesium (24Mg), strontium (88Sr) and zinc (
uide. The calcium 
g 
background signal for calcium. However, sensitivity was 
significantly reduced for other elements. 
gas significantly minimised the m/z 40
background on calcium and interferences on strontium 
without significant loss of sensitivity. 35 
2.5ml/min gave the best compromise of attenuation of 
background and minimal matrix interference whilst
maintaining signal sensitivity. 
 Elemental distribution maps 
magnesium and strontium in a 40 
in Figure 1. Element signals were normalised to
internal standard to compensate for changes in mass ablated or 
signal drift28, 29. Many of the tissue samples showed areas 
where it had folded or twisted over itself, i.e 
thicker in those areas. The use of45 
compensated for the difference in tissue thickness.
 Figure 1 shows corresponding regions of relatively high 
calcium and phosphorus intensities
taken from a patient with osteoarthritis. 
, [year], [vol], 00–00  |  3 
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Fig. 2 Elemental distribution maps of calcium (43Ca), phosphorus (
synovial fluid 
may be representative of calcium phosphate5 
deposits. A high frequency of CPPD crystals in articular 
tissues removed from OA hips and knees has been reported in 
the literature30. Other elements including copper, iron, 
selenium did not follow the same trend in distribution. 
 The areas are significantly larger than the average crystal 10 
size (up to 20µm)3. This may be due to aggregation of the 
crystals within the cartilage matrix. An alternative explanation 
was that the relatively larger laser spot size used for imaging
of the smaller crystals swamped the ICP-MS signal. That is,
the crystals sizes were magnified by the use of a spot size 15 
larger than the average crystal size. This may be overcome by 
higher resolution imaging.  
 In addition, several regions of relatively 
phosphate intensities correlated with relatively high 
magnesium and strontium intensities. Magnesium whitlockite, 20 
a calcium orthophosphate crystal in which calcium is partly 
substituted with magnesium, has been reported in both 
osetoarthritic and normal articular cartilage and recent dat
suggest it may play a pathological role in 
results were consistent with the association of magnesium 25 
whitlockite and BCP crystals as areas of relatively high 
magnesium intensities consistently overlapped
high calcium intensities. 
 Figure 1 also shows an area of relatively high strontium 
intensity which corresponded to areas of high calcium, 30 
phosphorus and magnesium. To our knowledge the association 
of strontium with BCP crystals has not been reported before, 
however it has been detected in osteoarthritic synovial fluid
Possible interferences of 88Sr include double charged rare 
earth elements, calcium dimers and argides, and calcium 35 
phosphates18, 34. When tuning the ICP-MS on NIST 612, the 
formation of diatomic interferences was monitored and found 
to be minimal. The reaction cell was shown to further reduce 
this. The signal collected from m/z 88 was identified as 
strontium as the Sr88/Sr86 isotope ratio agreed within the 40 
accepted range of natural abundances35. 
strontium distribution maps appear to be genuine
 An interesting trend in the distribution of zinc was also 
observed in some samples. Areas of high calcium, phosphorus 
and magnesium corresponded to regions of low zinc 45 
 This method also has the potential for ratio imaging. More 
objective and definitive detection of BCP crystals could be 
achieved by generating a 2D image of the Ca:P ratio, whereby 
areas with a ratio corresponding to that of BCP or CPPD 
This journal is © The Royal Society of Chemistry [year]
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crystals are selectively coloured against the remaining tissue. 
This may allow CPPD crystals to
crystals. 55 
Imaging of Synovial Fluids 
Synovial fluid is a more common sample type used by the 
many existing analytical tools for crystal detection and 60 
research as it is more accessible to the clinician. Therefore, 
imaging by LA ICP-MS was also trialled on dried synovial 
drops. 
 Synovial fluid was collected from patients suffering from 
OA and rheumatoid arthritis. A small volume (12µl) was then 
dropped onto a quartz coverslip and air dried. The laser 
experimental parameters ensured that the centre of the drop 70 
was completely ablated. The thicker outer
ablated completely. No sample preparation was necessary, an 
advantage against other methods such as XRF, which requires 
the crystals to be first isolated3. 
 BCP crystals are uniquely associated with OA and have 
been reported to occur in up to 60% of patient synovial 
samples3, 30. CPPD crystals have been associated with 30
OA synovial fluids30. Images consistent with the presence of 
crystal deposits were observed for 80 
both of the RA samples. Though BCP crystals are uniquely 
associated with OA3, the presence of CPPD crystals in RA 
joint fluids is not uncommon as these crystals are often found 
in many arthritides36. 
 Figure 2 shows the distribution of several elements in a 
drop of synovial fluid from an osteoarthritic joint. Simil
trends of common regions of relatively high calcium, 85 
phosphorus, magnesium and strontium were observed. An 
image of copper was included to illustrate th
distribution of elements not associated with calicum 
phosphate-based crystals. 
Confirmation of Crystal Imaging Using Synthetic Synovial 85 
Fluid 
Synovial fluid originates from plasma that is filtered by a 
capillary net and diffuses into the joint 
addition of locally synthesised hyaluronic acid, which is what 
gives SF its characteristic viscosity95 
fluid samples were prepared using human serum 
components of synovial fluid. After incubation of the solution, 
solid matter was observed. 
 The solution was filtered to remove the solid matter and 
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Fig. 3a Elemental distribution maps of calcium (
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Fig. 3b Elemental distribution maps of calcium (43
fluid 
drops of both filtered and non-filtered solution were left to air 
dry on a clean slide. As the fluid was not as viscous as 10 
synovial fluid, the spot was not as thick and a faster scan rate 
could be applied whilst still ensuring complete ablation.
 Images of the elemental distribution of calcium, 
phosphorus, magnesium and strontium are presented in Figure 
3a. Again, results consistent with the presence of crystal15 
deposits were observed in these images by common regions of 
relatively high intensities of crystal-associa
 In distinct contrast, the images produced from the ablation 
of the filtered solution do not show the small common regions 
that are consistent with crystal deposits (Figure 3b)20 
images instead show a more uniform distribution of the 
elements with increasing concentration radiating out from the 
centre of the spot, similar to that seen for non
associated elements in the synovial fluid sample
the common size of CPPD crystals, filtration at 0.22µm 25 
should remove any crystals or solid matter that formed in the 
solution. 
 The presence of CPPD or BCP crystals in the cartilage or 
synovial fluid samples was not confirmed by other methods 
currently used for this purpose. However, thi30 
study gives a good indication of the potential of 
to the detection of BCP and CPPD crystals in both cartilage 
and synovial fluid samples. Additionally, the 
phosphorus ratio may be used to identify the crystals present. 
Further studies are currently being pursued to confirm crystal 35 
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presence by SEM prior to laser ablation. This would validate 
the method in terms of false positives/negatives and 40 
sensitivity limits compared to o
 Additionally, quantification data may be obtained using 
standard serum solutions for spot calibration and matrix 
matched standardised tissue for cartilage samples.
Conclusions 
This study has illustrated the potential of LA ICP
identification of crystal deposits in biological tissues and 
fluids through their localised elemental distributions. The 
distribution of BCP and CPPD crystal55 
including calcium, phosphorus and magnesium, considered 
consistent with the presence of crystal deposits, was observed 
in osteoarthritic knee cartilage and synovial fluid samples by 
LA ICP-MS. Future studies will focus on quantification, 
validation of crystals by SEM and ratio imaging.60 
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